These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1389947)

  • 1. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses.
    Ferrara SD; Zotti S; Tedeschi L; Frison G; Castagna F; Gallimberti L; Gessa GL; Palatini P
    Br J Clin Pharmacol; 1992 Sep; 34(3):231-5. PubMed ID: 1389947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and excretion of gamma-hydroxybutyrate (GHB) in healthy subjects.
    Brenneisen R; Elsohly MA; Murphy TP; Passarelli J; Russmann S; Salamone SJ; Watson DE
    J Anal Toxicol; 2004; 28(8):625-30. PubMed ID: 15538955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers.
    Palatini P; Tedeschi L; Frison G; Padrini R; Zordan R; Orlando R; Gallimberti L; Gessa GL; Ferrara SD
    Eur J Clin Pharmacol; 1993; 45(4):353-6. PubMed ID: 8299669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
    Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
    Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. γ-Hydroxybutyric Acid: Pharmacokinetics, Pharmacodynamics, and Toxicology.
    Felmlee MA; Morse BL; Morris ME
    AAPS J; 2021 Jan; 23(1):22. PubMed ID: 33417072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gamma-hydroxybutyrate (GHB) in humans: pharmacodynamics and pharmacokinetics.
    Abanades S; Farré M; Segura M; Pichini S; Barral D; Pacifici R; Pellegrini M; Fonseca F; Langohr K; De La Torre R
    Ann N Y Acad Sci; 2006 Aug; 1074():559-76. PubMed ID: 17105953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-high-performance liquid chromatography tandem mass spectrometry determination of GHB, GHB-glucuronide in plasma and cerebrospinal fluid of narcoleptic patients under sodium oxybate treatment.
    Tittarelli R; Pichini S; Pedersen DS; Pacifici R; Moresco M; Pizza F; Busardò FP; Plazzi G
    Forensic Sci Int; 2017 May; 274():70-74. PubMed ID: 28139340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data.
    Addolorato G; Leggio L; Ferrulli A; Caputo F; Gasbarrini A
    Expert Opin Investig Drugs; 2009 May; 18(5):675-86. PubMed ID: 19379123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients.
    Borgen LA; Okerholm RA; Lai A; Scharf MB
    J Clin Pharmacol; 2004 Mar; 44(3):253-7. PubMed ID: 14973300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
    Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
    Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Monocarboxylate Transporter Inhibitor as a Potential Treatment Strategy for γ-Hydroxybutyric Acid Overdose.
    Vijay N; Morse BL; Morris ME
    Pharm Res; 2015 Jun; 32(6):1894-906. PubMed ID: 25480120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects.
    Borgen LA; Okerholm R; Morrison D; Lai A
    J Clin Pharmacol; 2003 Jan; 43(1):59-65. PubMed ID: 12520629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
    van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
    Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group.
    Addolorato G; Castelli E; Stefanini GF; Casella G; Caputo F; Marsigli L; Bernardi M; Gasbarrini G
    Alcohol Alcohol; 1996 Jul; 31(4):341-5. PubMed ID: 8879280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of gammahydroxybutyrate (GHB) in narcoleptic patients.
    Scharf MB; Lai AA; Branigan B; Stover R; Berkowitz DB
    Sleep; 1998 Aug; 21(5):507-14. PubMed ID: 9703591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of 1,4-butanediol in rats: bioactivation to gamma-hydroxybutyric acid, interaction with ethanol, and oral bioavailability.
    Fung HL; Tsou PS; Bulitta JB; Tran DC; Page NA; Soda D; Mi Fung S
    AAPS J; 2008; 10(1):56-69. PubMed ID: 18446506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral self-administration of gamma-hydroxybutyric acid in the rat.
    Colombo G; Agabio R; Balaklievskaia N; Diaz G; Lobina C; Reali R; Gessa GL
    Eur J Pharmacol; 1995 Oct; 285(1):103-7. PubMed ID: 8846805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid.
    Ferrara SD; Tedeschi L; Frison G; Orlando R; Mazzo M; Zordan R; Padrini R; Palatini P
    Eur J Clin Pharmacol; 1996; 50(4):305-10. PubMed ID: 8803524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomised comparative study.
    Caputo F; Addolorato G; Stoppo M; Francini S; Vignoli T; Lorenzini F; Del Re A; Comaschi C; Andreone P; Trevisani F; Bernardi M;
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):781-9. PubMed ID: 17611081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.